Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
335 words
A method to detect, photosensitize, destroy or impair the functioning of target biological material which comprises contacting said target with an effective amount of a hydro-monobenzoporphyrin (Gp) having a light absorption maximum between 670-780 nm; wherein the Gp is selected from the group consisting of ##STR17## and mixtures thereof and the metalated and labeled forms thereof, wherein each R 1 and R 2 independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, Aryl (6-10C) sulfonyl, aryl (6-10C); cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C) each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and R 4 is CHCH 2 , CH 2 OR 4' , --CHO, --COOR 4 CH(OR 4' )CH 3 , CH(OR 4' )CH 2 OR 4' , --CH(SR 4' )CH 3 , --CH(NR 2 )CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 , --CH((OOCR 4' )CH 3 , --CH(halo)CH or --CH(halo)CH 2 (halo), wherein R 4' is H, alkyl (1-6C) optionally substituted with a hydrophilic substituent, or wherein R 4 is an organic noninterfering group of <12C resulting from direct or indirect derivatization of vinyl, or wherein R 4 consists of 1-3 tetrapyrrole-type nuclei of the formula --L--P wherein --L-- is selected from the group consisting of ##STR18## and P is selected from the group consisting of Gp which is of the formula 1-6 but lacking R 4 and conjugated through the position shown as occupied by R 4 to L, and a porphyrin of the formula: ##STR19## wherein each R is independently H or lower alkyl (1-4C); wherein two of the bonds shown as unoccupied on adjacent rings are joined to R 3 and one of the remaining bonds shown as unoccupied is joined to R 4 and the other to L; with the proviso that if R 4 is CHCH 2 , both R 3 cannot be carbalkoxyethyl; and irradiating said target with light absorbed by said Gp.
Claim 2
Independent Claim
335 words
A method to detect, photosensitize, destroy or impair the functioning of target biological material which comprises contacting said target with an effective amount of a hydro-monobenzoporphyrin (Gp) having a light absorption maximum between 670-780 nm; wherein the Gp is selected from the group consisting of ##STR17## and mixtures thereof and the metalated and labeled forms thereof, wherein each R 1 and R 2 independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, Aryl (6-10C) sulfonyl, aryl (6-10C); cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C) each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and R 4 is CHCH 2 , CH 2 OR 4' , --CHO, --COOR 4 CH(OR 4' )CH 3 , CH(OR 4' )CH 2 OR 4' , --CH(SR 4' )CH 3 , --CH(NR 2 )CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 , --CH((OOCR 4' )CH 3 , --CH(halo)CH or --CH(halo)CH 2 (halo), wherein R 4' is H, alkyl (1-6C) optionally substituted with a hydrophilic substituent, or wherein R 4 is an organic noninterfering group of <12C resulting from direct or indirect derivatization of vinyl, or wherein R 4 consists of 1-3 tetrapyrrole-type nuclei of the formula --L--P wherein --L-- is selected from the group consisting of ##STR18## and P is selected from the group consisting of Gp which is of the formula 1-6 but lacking R 4 and conjugated through the position shown as occupied by R 4 to L, and a porphyrin of the formula: ##STR19## wherein each R is independently H or lower alkyl (1-4C); wherein two of the bonds shown as unoccupied on adjacent rings are joined to R 3 and one of the remaining bonds shown as unoccupied is joined to R 4 and the other to L; with the proviso that if R 4 is CHCH 2 , both R 3 cannot be carbalkoxyethyl; and irradiating said target with light absorbed by said Gp.
Claim 3
Independent Claim
23 words
The method of claim I wherein each R 3 is --CH 2 CH 2 COOH or a salt, amide, ester or acylhydrazone thereof.
Claim 4
Dependent Claim
16 words
The method of claim 1 wherein each of R 1 and R 2 is carbalkoxy (2-6C).
Claim 5
Dependent Claim
16 words
The method of claim 2 wherein each of R 1 and R 2 is carbalkoxy (2-6C).
Claim 6
Dependent Claim
13 words
The method of claim 1 wherein the Gp has formula 3 or 4.
Claim 7
Dependent Claim
13 words
The method of claim 4 wherein the Gp has formula 3 or 4.
Claim 8
Dependent Claim
144 words
The method of claim 1 wherein the Gp has formula 3 or 4 and mixtures thereof, and wherein each R 1 and R 2 independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, aryl (6-10C) sulfonyl, aryl (6-10C) cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); R 4 is CHCH 2 CH 2 OR 4' , --CHO, --COOR 4' , CH(OR 4' )CH 3 , CH(OR 4' )CH 2 OR 4' , --CH(SR 4' )CH 3 , --CH(NR 4' 2 )CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 , --CH((OOCR 4' )CH 3 , --CH(halo)CH 3 , or --CH(halo)CH 2 (halo), wherein R 4' is H, alkyl (1-6C) optionally substituted with a hydrophilic substituent.
Claim 9
Dependent Claim
92 words
The method of claim 1 wherein the Gp has formula 3 or 4 and mixtures thereof, and wherein each R 1 and R 2 is independently selected from the group consisting of carbalkoxy, alkyl (1-6C) sulfonyl, aryl (6-10C) sulfonyl, aryl (6-10C) cyano; and --CONR 5 CO-- wherein R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and wherein R 4 is a substituent containing 1-3 tetrapyrrole-type nuclei, of the formula --L--P as herein defined.
Claim 10
Dependent Claim
34 words
The method of claim 1 wherein the target materials are cells or tissue harbored in a subject and said contacting comprises administering the Gp in vivo to said subject harboring said cells or tissue.
Claim 11
Dependent Claim
13 words
The method of claim 9 wherein the administering is by an oral route.
Claim 12
Dependent Claim
10 words
The method of claim 9 wherein the administering is topical.
Claim 13
Dependent Claim
11 words
The method of claim 9 wherein the administering is by injection.
Claim 14
Dependent Claim
12 words
The method of claim 9 wherein the Gp further contains a label.
Claim 15
Dependent Claim
19 words
The method of claim 13 wherein the label is selected from the group consisting of technetium, gallium and indium.
Claim 16
Dependent Claim
14 words
The method of claim 1 wherein the target is contained in a biological fluid.
Claim 17
Dependent Claim
14 words
The method of claim 15 wherein the biological fluid is blood or blood plasma.
Claim 18
Dependent Claim
12 words
The method of claim 16 wherein the fluid is treated ex vivo.
Claim 19
Dependent Claim
33 words
The method of claim 1 wherein said method is to photosensitize, destroy or impair the functioning of target biological material, and where said irradiating is conducted with light of wavelength between 670-780 nm.
Claim 20
Dependent Claim
13 words
The method of claim 18 wherein said irradiation is supplied by a laser.
Claim 21
Dependent Claim
14 words
The method of claim 18 wherein said irradiation is supplied by a light-emitting diode.
Claim 22
Dependent Claim
14 words
The method of claim 1 wherein the target material is the lesions of psoriasis.
Claim 23
Dependent Claim
12 words
The method of claim 1 wherein the target material is atherosclerotic plaque.
Claim 24
Dependent Claim
12 words
The method of claim 1 wherein the target material is a virus.
Claim 25
Dependent Claim
23 words
The method of claim 1 which is to detect the target biological material and wherein said irradiating excites said Gp to emit fluorescence.
Claim 26
Dependent Claim
57 words
A method to detect or impair the metabolism of or to effect the destruction of target virus, cells, or tissues which comprises contacting said target with an effective amount of the Gp compound as defined in claim 1, or a pharmaceutical composition thereof, and irradiating the contacted virus, cells, or tissues with light absorbed by the Gp.
Claim 27
Dependent Claim
19 words
The method of claim 25 wherein the target comprises cells selected from tumor cells, T-suppressor cells and infective cells.